The role of RNase L in kidney function

RNase L 在肾功能中的作用

基本信息

  • 批准号:
    10730414
  • 负责人:
  • 金额:
    $ 44.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Acute kidney injury (AKI) is an abrupt loss of kidney function from various causes, which may lead to several complications, including metabolic acidosis, hyperkalemia, uremia, increased extracellular fluid volume, and death. Exogenous administration of epidermal growth factor (EGF) has been found to enhance regeneration and repair renal tubule cells and accelerate the recovery of renal function in post-ischemic and nephrotoxin-induced AKI. On the other hand, activation of the EGF receptor (EGFR) also contributes to development and progression of chronic kidney diseases (CKD). Clearly, the activation of EGF/EGFR plays an uncertain role, as it can be either beneficial or detrimental to renal function after AKI. A better understanding of its regulation in the kidney is, therefore, of importance. In this study, we hypothesize that RNase L is a very important regulator in renal function, under basal circumstances, by permitting ADAM10- dependent tubular EGF secretion, which regulates normal kidney development and growth. In the context of AKI and tubular injury, these same pathways are essential for repair, but need to be appropriately downregulated to prevent the transition of AKI to CKD. The hypothesis is based on the results we recently obtained that 1) kidney size was significantly reduced in RNase L knockout mice compared to wild-type mice, which was more pronounced after aging; 2) urine EGF is completely abolished in RNase L knockout mice; 3) RNase L mediated the expression and maturation of A Disintegrin and Metalloproteinase Domain 10 (ADAM10), a transmembrane metalloprotease responsible for the shedding and releasing of the EGF precursor in the kidney; and 4) RNase L knockout mice were recovered much faster than RNase L wild type mice from folic acid (FA)-induced AKI through activation of the PI3K/AKT pathway. The specific aims are to investigate the molecular mechanisms by which RNase L regulates the EGF excretion in urine and the role of RNase L in kidney function under normal and pathological conditions and explore whether RNase L is involved in AKI to CKD transition. Our study will provide novel insights into how RNase L regulates the homeostasis of the EGF family of ligands and activation of the receptors, which are vital in renal development, aging, physiology and pathophysiology. Most importantly, the project will offer a unique opportunity for more undergraduate students to be trained in the disease-related basic sciences.
急性肾脏损伤(AKI)是由于各种原因突然丧失了肾功能,这可能导致 几种并发症,包括代谢性酸中毒,高钾血症,尿毒症,增加 细胞外流体体积和死亡。表皮生长因子(EGF)的外源给药 已经发现可以增强再生和修复肾小管细胞并加速恢复 缺血后和肾毒素诱导的AKI中的肾功能。另一方面,激活 EGF受体(EGFR)也有助于慢性肾脏的发展和发展 疾病(CKD)。显然,EGF/EGFR的激活起着不确定的作用,因为它可以是 AKI后对肾功能有益或有害。更好地理解其在 因此,肾脏很重要。在这项研究中,我们假设RNase L是一个非常 在基础情况下,肾功能中的重要调节剂通过允许ADAM10- 依赖性管状EGF分泌,调节正常的肾脏发育和生长。 在AKI和管状损伤的背景下,这些相同的途径对于维修至关重要,但是 需要适当地下调以防止AKI向CKD过渡。这 假设基于我们最近获得的结果,即1)肾脏大小显着 与野生型小鼠相比,RNASE L敲除小鼠的减少,这更明显 衰老后; 2)尿液EGF在RNase L敲除小鼠中被完全废除; 3)rNase l介导 崩解蛋白和金属蛋白酶结构域10(ADAM10)的表达和成熟 跨膜金属蛋白酶负责脱落和释放EGF前体 在肾脏; 4)RNase L敲除小鼠的回收速度比RNase L野生型快得多 来自叶酸(FA)的小鼠通过激活PI3K/AKT途径诱导了AKI。具体 目的是研究RNase l调节EGF排泄的分子机制 在尿液和RNase L在正常和病理条件下肾功能中的作用以及 探索RNase L是否参与AKI到CKD转变。我们的研究将提供新颖的见解 rnase如何调节EGF配体家族的稳态和激活 受体,对肾脏发育,衰老,生理和病理生理学至关重要。最多 重要的是,该项目将为更多的本科生提供独特的机会 接受与疾病相关的基本科学的培训。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AIMIN ZHOU其他文献

AIMIN ZHOU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AIMIN ZHOU', 18)}}的其他基金

The involvement of RNase L in the pathogenesis of inflammatory bowel disease
RNase L参与炎症性肠病发病机制
  • 批准号:
    8036416
  • 财政年份:
    2011
  • 资助金额:
    $ 44.55万
  • 项目类别:
The Role of RNase L in Cardiovascular Diseases
RNase L 在心血管疾病中的作用
  • 批准号:
    7060750
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:
The Role of RNase L in Cardiovascular Diseases
RNase L 在心血管疾病中的作用
  • 批准号:
    6854416
  • 财政年份:
    2005
  • 资助金额:
    $ 44.55万
  • 项目类别:

相似海外基金

The role of amphiregulin in mediating radiation cystitis in cancer survivors
双调蛋白在介导癌症幸存者放射性膀胱炎中的作用
  • 批准号:
    10636699
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
Cellular and Molecular Response to Gentamicin-Induced Injury in Underdeveloped Kidneys
发育不全的肾脏对庆大霉素引起的损伤的细胞和分子反应
  • 批准号:
    10591824
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
Defining The Role of Failed-Repair Proximal Tubule Cells in AdvancedRenal Disease in African Americans
确定修复失败的近端小管细胞在非裔美国人晚期肾病中的作用
  • 批准号:
    10740665
  • 财政年份:
    2023
  • 资助金额:
    $ 44.55万
  • 项目类别:
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
肝硬化患者肾脏健康的新型生物标志物对急性肾损伤发生风险和可逆性的分层
  • 批准号:
    10675684
  • 财政年份:
    2022
  • 资助金额:
    $ 44.55万
  • 项目类别:
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
  • 批准号:
    10611485
  • 财政年份:
    2022
  • 资助金额:
    $ 44.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了